News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,847 Results
Type
Article (39232)
Company Profile (282)
Press Release (650333)
Section
Business (203946)
Career Advice (1999)
Deals (35386)
Drug Delivery (89)
Drug Development (80885)
Employer Resources (168)
FDA (16112)
Job Trends (14815)
News (344729)
Policy (32455)
Tag
Academia (2530)
Alliances (49259)
Alzheimer's disease (1290)
Approvals (16078)
Artificial intelligence (160)
Bankruptcy (354)
Best Places to Work (11603)
Biotechnology (199)
Breast cancer (204)
Cancer (1518)
Cardiovascular disease (121)
Career advice (1665)
CAR-T (106)
Cell therapy (312)
Clinical research (64928)
Collaboration (566)
Compensation (307)
COVID-19 (2549)
C-suite (133)
Data (1467)
Diabetes (189)
Diagnostics (6197)
Earnings (85027)
Employer resources (146)
Events (110348)
Executive appointments (482)
FDA (16885)
Funding (513)
Gene therapy (214)
GLP-1 (621)
Government (4338)
Healthcare (18738)
Infectious disease (2646)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16393)
Job creations (3625)
Job search strategy (1418)
Layoffs (424)
Legal (7870)
Lung cancer (225)
Manufacturing (214)
Medical device (13231)
Medtech (13236)
Mergers & acquisitions (19258)
Metabolic disorders (493)
Neuroscience (1651)
NextGen: Class of 2025 (6506)
Non-profit (4471)
Northern California (1863)
Obesity (281)
Opinion (186)
Patents (133)
People (56638)
Phase I (20208)
Phase II (28592)
Phase III (21304)
Pipeline (613)
Postmarket research (2561)
Preclinical (8554)
Radiopharmaceuticals (239)
Rare diseases (285)
Real estate (5893)
Regulatory (21783)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1612)
Startups (3565)
United States (16612)
Vaccines (578)
Weight loss (194)
Date
Today (115)
Last 7 days (390)
Last 30 days (1954)
Last 365 days (34851)
2025 (1701)
2024 (35252)
2023 (40077)
2022 (51173)
2021 (55711)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (203)
Asia (37391)
Australia (6104)
California (4236)
Canada (1553)
China (361)
Colorado (190)
Connecticut (205)
Europe (80062)
Florida (605)
Georgia (147)
Illinois (413)
Indiana (242)
Maryland (685)
Massachusetts (3277)
Michigan (183)
Minnesota (316)
New Jersey (1183)
New York (1203)
North Carolina (784)
Northern California (1863)
Ohio (154)
Pennsylvania (999)
South America (1093)
Southern California (1612)
Texas (615)
Utah (119)
Washington State (428)
689,847 Results for "curebase inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Curebase Announces Omnisite™ Offering to Recruit and Enroll Patients Anywhere
Curebase, a company committed to democratizing access to clinical studies and a leader in decentralized clinical trial execution, is now offering Omnisite™, a flexible site model that leverages a number of the company’s existing capabilities to reach patients where they are at home and in real-world medical settings.
June 13, 2023
·
2 min read
Business
Curebase and BEKHealth Join Forces to Expand Access to Decentralized Clinical Trials
Curebase to Leverage BEKHealth’s Integrated Clinical Research Platform to More Easily Find and recruit Decentralized Trial Participants, Expand into Oncology and New Therapeutic Areas.
November 15, 2022
·
3 min read
Business
Curebase Partners with Redenlab to Expand Data Capture Capabilities in Pharma Trials
Curebase, a company dedicated to democratizing clinical trials through a decentralized model is announcing its partnership with Redenlab, a global leader for speech testing in industry-run clinical trials.
December 1, 2022
·
2 min read
Biotech Bay
Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials
Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics trials that accelerates enrollment and allows sponsors to launch their studies faster.
January 24, 2023
·
3 min read
Business
Curebase Names Medical Research Veteran Sean Lynch as VP of Clinical Operations
Curebase, a company committed to democratizing access to clinical studies, has named veteran clinical research executive Sean Lynch as vice president of clinical operations.
August 23, 2022
·
2 min read
Business
Curebase Adds Two Clinical Trial Veterans to Kick-off New Advisory Board
Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board.
February 14, 2022
·
3 min read
Biotech Bay
Curebase Secures $40 Million in Series B Funding
Curebase has raised $40 million in Series B funding to continue development of its end-to-end clinical trial execution model, virtual and hybrid site capabilities, and full eClinical software platform to run modern, patient-centric clinical trials.
May 5, 2022
·
4 min read
Biotech Bay
Curebase selected to launch a clinical investigation of a digital therapeutic for IPF
Curebase, a company committed to democratizing access to clinical studies, today announced the initiation of the pilot phase of COMPANION, the first clinical investigation of a new digital therapeutic (DTx) for patients with IPF, a rare lung disease.
April 21, 2022
·
5 min read
Press Releases
DiFusion Inc., Announces New Patent
January 14, 2025
·
1 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
1 of 68,985
Next
